iA partners with Euclid Medical ProductsiA’s NEXiA Enterprise Software Suite will integrate Euclid’s Axial Adherence Packaging Technology into centralized fulfillment solutions. U.S. District Court dismisses Norwich’s lawsuit against the FDA over generic XifaxanNorwich asked the District Court to direct the FDA in granting immediate approval for generic Xifaxan (rifaximin) 550 mg. Healing the healthcare system Empowering pharmacists to keep us healthy is critical for the industry. FDA approves Amgen’s Wezlana biosimilar Wezlana is used to treat multiple inflammatory diseases. Theravance, Mylan settle patent litigation with Teva over Yupelri Teva has been granted a royalty-free, non-exclusive license to market generic Yupelri in the United States on or after April 23, 2039. NACDS’ health, wellness initiatives take center stage at 2023 Milken Institute Future of Health Summit NACDS’ initiatives regarding health and wellness were on display at the 2023 Milken Institute Future of Health Summit. Phathom Pharmaceuticals receives FDA nod for Voquezna Voquezna is a new treatment for adults for the healing and maintenance of all grades of erosive esophagitis. Alembic debuts 2 generics Alembic is introducing generic chlorpromazine hydrochloride tablets and generic Combigan. Pharmacy orgs laud bipartisan Senate Finance Committee vote to advance PBM reforms in Medicare, Medicaid The Senate Finance Committee advanced the legislation on a strong bipartisan vote of 26-0, with one ‘present.’ Somerset intros generic calcium gluconate Calcium gluconate is an essential medicine used in the treatment of acute symptomatic hypocalcemia in pediatric and adult patients. First Previous 61 62 63 64 65 Next Last
